JOSE EMILIO
SANCHEZ ALVAREZ
Profesor Asociado en CC. Salud
Publicaciones (61) Publicaciones de JOSE EMILIO SANCHEZ ALVAREZ
2023
-
Etiopathogenesis of chronic kidney disease-associated pruritus: putting the pieces of the puzzle together
Nefrologia, Vol. 43, Núm. 1, pp. 48-62
-
Impact of peritoneal dialysis strategy on technique and patient survival
Clinical Kidney Journal, Vol. 16, Núm. 12, pp. 2523-2529
-
Management of immunosuppressive therapy in kidney transplant recipients with COVID-19. A multicentre national study derived from the Spanish Society of Nephrology COVID registry
Nefrologia, Vol. 43, Núm. 4, pp. 442-451
-
Outcomes of COVID-19 in peritoneal dialysis patients: A report by the European Renal Association COVID-19 Database
Peritoneal Dialysis International, Vol. 43, Núm. 1, pp. 23-36
-
Perception of Spanish nephrologists on an old unsolved problem: Pruritus associated with chronic kidney disease (CKD-aP)
Nefrologia, Vol. 43, Núm. 1, pp. 102-110
-
Preparing European Nephrology for the next pandemic: Lessons from the ERACODA collaboration
Nephrology Dialysis Transplantation, Vol. 38, Núm. 3, pp. 575-582
2022
-
Changing trends in presentation and indications of biopsy in lupus nephritis: Data from the Spanish Registry of Glomerulonephritis
Clinical Kidney Journal, Vol. 15, Núm. 4, pp. 703-708
-
Evolving spectrum but persistent high mortality of COVID-19 among patients on kidney replacement therapy in the vaccine era: The Spanish COVID-19 KRT Registry
Clinical Kidney Journal, Vol. 15, Núm. 9, pp. 1685-1697
-
Hepatotoxicity induced by tolvaptan: A case report
Nefrologia
-
Kidneys also speak Spanish: Initiatives towards standardisation of our nephrology nomenclature
Nefrologia, Vol. 42, Núm. 3, pp. 223-232
-
Living Well With Kidney Disease and Effective Symptom Management: Consensus Conference Proceedings
Kidney International Reports
2021
-
COVID-19 vaccination among Spanish nephrologists: Acceptance and side effects
Journal of Healthcare Quality Research, Vol. 36, Núm. 6, pp. 363-369
-
ERACODA: The European database collecting clinical information of patients on kidney replacement therapy with COVID-19
Nephrology Dialysis Transplantation, Vol. 35, Núm. 12, pp. 2023-2025
-
Efficacy and safety of sucroferric oxyhydroxide in the treatment of hyperphosphataemia in chronic kidney disease in Asturias. FOSFASTUR study
Nefrologia, Vol. 41, Núm. 1, pp. 45-52
-
Erratum: COVID-19-related mortality in kidney transplant and dialysis patients: Results of the ERACODA collaboration (Nephrology Dialysis Transplantation (2020) 35:11 (1973-1983) DOI: 10.1093/ndt/gfaa261)
Nephrology Dialysis Transplantation
-
Global Dialysis Perspective: Spain
Kidney360, Vol. 2, Núm. 2, pp. 344-349
-
On the need to harmonize nephrological terminology in Ibero-American countries
Nefrologia
-
Position statement of the Spanish Society of Nephrology on the SARS-CoV-2 vaccines
Nefrologia, Vol. 41, Núm. 4, pp. 412-416
-
Predictors of severe COVID-19 in kidney transplant recipients in the different epidemic waves: Analysis of the Spanish Registry
American Journal of Transplantation, Vol. 21, Núm. 7, pp. 2573-2582
-
Real-world management of hyperphosphataemia with sucroferric oxyhydroxide: The VELREAL multicentre study
Clinical Kidney Journal, Vol. 14, Núm. 2, pp. 681-687